Talk:MDAT

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on Wikipedia's content assessment scale.
???	This article has not yet received a rating on the project's importance scale.

Chemicals Stub‑class Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Stub	This article has been rated as Stub-class on Wikipedia's content assessment scale.
Low	This article has been rated as Low-importance on the project's importance scale.

I rewort the article because although there was a source, the info in the wiki page was completely contradictory to the results of the rat study. This is most likely because it is being sold as a research chemical, and vendors want to make it seem worthwhil to purchase. I will quote the lines that prove this:

6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm (5,6-(methylenedioxy)-2-aminotetralin is MDAT, called 4b in the study)

Now the results: Compounds 4a and 4b did not substitute in MDMA-trained rats

HOWEVER 3b fully substituted in MDMA-trained rats

6,7-(methylenedioxy)-2-aminotetralin substitues for MDMA in rats 5,6-(methylenedioxy)-2-aminotetralin DOES NOT --Rollie (talk) 11:33, 2 June 2010 (UTC)[reply]